Sulfamethoxazole

This MedLibrary.org supplementary page on Sulfamethoxazole is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Sulfamethoxazole
Systematic (IUPAC) name
4-amino-N-(5-methylisoxazol-3-yl)-benzenesulfonamide
Identifiers
CAS number 723-46-6
ATC code J01EC01
PubChem 5329
DrugBank APRD00076
Chemical data
Formula C10H11N3O3S 
Mol. mass 253.279 g/mol
SMILES eMolecules & PubChem
Physical data
Melt. point 3 °C (37 °F)
Pharmacokinetic data
Bioavailability  ?
Protein binding 70%
Metabolism Hepatic acetylation and glucuronidation
Half life 10 hours
Excretion Renal
Therapeutic considerations
Pregnancy cat.

C (Au, U.S.)

Legal status

Prescription Only (S4)(AU) ℞-only

Routes Oral

Sulfamethoxazole is a sulfonamide bacteriostatic antibiotic. It is most often used as part of a synergistic combination with trimethoprim in a 5:1 ratio in co-trimoxazole, which is also known as Bactrim, Septrin, or Septra (also abbreviated SMX/TMP). Its primary activity is against susceptible forms of Streptococcus, Staphylococcus aureus, Escherichia coli, Haemophilus influenzae, and oral anaerobes. It is commonly used to treat urinary tract infections. In addition can be used as an alternative to amoxicillin-based antibiotics to treat sinusitis. It can also be used to treat toxoplasmosis.

Contents

Mechanism of action

Sulfonamides are structural analogs and competitive antagonists of para-aminobenzoic acid (PABA). They inhibit normal bacterial utilization of PABA for the synthesis of folic acid, an important metabolite in DNA synthesis.[1] The effects seen are usually bacteriostatic in nature. Folic acid is not synthesized in humans, but is instead a dietary requirement. This allows for the selective toxicity to bacterial cells (or any cell dependent on synthesizing folic acid) over human cells. Bacterial resistance to sulfamethoxazole are caused by mutations in the folic acid enzyme that do the drugs from binding and blocking folic acid synthesis.

Tetrahydrofolate synthesis pathway
Tetrahydrofolate synthesis pathway

Side effects

The most common side effect of sulfamethoxazole/trimethoprim is gastrointestinal upset. Allergies to sulfa-based medications typically cause skin rashes, hives, or trouble breathing or swallowing and warrant immediate discontinuation of the medication and contact with doctor immediately. Sulfamethoxazole/trimethoprim is also known to increase blood concentrations of the drug warfarin (U.S. brand name: Coumadin) and can cause an unexpected increase in clotting time and uncontrolled bleeding. Neutropenia and thrombocytopenia also are rare adverse effects to be monitored if a patient is placed on long-term therapy.

Gardnerella

A TM-SXT (or simply SXT) disk impregnated with trimethoprim and sulfamethoxazole may be used to help identify an organism as Gardnerella vaginalis; it is sensitive to the TM-SXT disk.

References

  1. ^ Martindale, The extra pharmacopoeia, 30th ed, p. 208

External links

See also

Wikipedia content modification information:

  • This page was last modified on 18 September 2008, at 00:11.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Sulfamethoxazole".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.